Literature DB >> 19006102

Metabolite profiling of fecal water extracts from human colorectal cancer.

Daniel Monleón1, José Manuel Morales, Antonio Barrasa, Jose Antonio López, Carlos Vázquez, Bernardo Celda.   

Abstract

Colorectal cancer is the second leading cause of cancer death in developed countries. There is a need for better preventive strategies to improve the outcome of this disease. The increasing availability of high-throughput methodologies opens up new possibilities for screening new markers. The application of NMR metabolic profiling to fecal water extracts has interesting potential as a diagnostic tool for detecting colorectal cancer. We obtained NMR metabolic profiles of fecal water extracts from patients with colorectal cancer and healthy individuals, to characterize possible differences between them and to identify potential diagnostic markers. Our results show that metabolic profiling of fecal water extracts is a cheap, reproducible and effective method for detecting colorectal cancer markers and therefore complements other stool-screening methods. A low concentration of short-chain fatty acids, such as acetate and butyrate, previously associated with the development of colorectal cancer, appears to be the most effective marker. Concentrations of proline and cysteine, which are major components of most colonic epithelium mucus glycoproteins, also display significant changes in samples from colorectal cancer. Differentiation between fecal water extracts from controls and patients with colorectal cancer by NMR spectroscopy combined with chemometric techniques opens up new possibilities for developing new, efficient, high-throughput screening protocols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19006102     DOI: 10.1002/nbm.1345

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  56 in total

1.  Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.

Authors:  Lingli Deng; Haiwei Gu; Jiangjiang Zhu; G A Nagana Gowda; Danijel Djukovic; E Gabriela Chiorean; Daniel Raftery
Journal:  Anal Chem       Date:  2016-08-01       Impact factor: 6.986

Review 2.  Metabolomics: moving to the clinic.

Authors:  Anders Nordström; Rolf Lewensohn
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-28       Impact factor: 4.147

3.  Fecal metabolomics: assay performance and association with colorectal cancer.

Authors:  James J Goedert; Joshua N Sampson; Steven C Moore; Qian Xiao; Xiaoqin Xiong; Richard B Hayes; Jiyoung Ahn; Jianxin Shi; Rashmi Sinha
Journal:  Carcinogenesis       Date:  2014-07-18       Impact factor: 4.944

4.  Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.

Authors:  Upender Manne; Trafina Jadhav; Balananda-Dhurjati Kumar Putcha; Temesgen Samuel; Shivani Soni; Chandrakumar Shanmugam; Esther A Suswam
Journal:  Curr Colorectal Cancer Rep       Date:  2016-09-20

5.  Metabolomic study of serum from rabbits with acute acalculous cholecystitis.

Authors:  Zhituo Li; Huaishu Shen; Yingmei Zhang; Ming Lu; Xin Qiao; Xianzhi Meng; Bei Sun; Dongbo Xue; Weihui Zhang
Journal:  Inflamm Res       Date:  2012-05-23       Impact factor: 4.575

6.  Determination of urinary 5-hydroxyindoleacetic acid as a metabolomics in gastric cancer.

Authors:  Maral Mokhtari; Amin Rezaei; Ali Ghasemi
Journal:  J Gastrointest Cancer       Date:  2015-06

7.  The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation.

Authors:  Dallas R Donohoe; Leonard B Collins; Aminah Wali; Rebecca Bigler; Wei Sun; Scott J Bultman
Journal:  Mol Cell       Date:  2012-10-11       Impact factor: 17.970

8.  Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage.

Authors:  Haiwei Gu; Ping Zhang; Jiangjiang Zhu; Daniel Raftery
Journal:  Anal Chem       Date:  2015-12-02       Impact factor: 6.986

9.  Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia.

Authors:  David C Montrose; Xi Kathy Zhou; Levy Kopelovich; Rhonda K Yantiss; Edward D Karoly; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2012-09-07

10.  Non-invasive fecal metabonomic detection of colorectal cancer.

Authors:  Lee Cheng Phua; Xiu Ping Chue; Poh Koon Koh; Peh Yean Cheah; Han Kiat Ho; Eric Chun Yong Chan
Journal:  Cancer Biol Ther       Date:  2014-01-14       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.